Table 1: Detail of the Treated Patients and Related Information

Nb Pat Sex Age Primary disease BiP Treatment Length of BiP treatment (months) Triggering cause of BRONJ Osteonecrotic area ONJ Classification Time between start of BiP intake and BRONJ diagnosis (months) Time between end of BiP intake and BRONJ diagnosis (months) Time between surgery and last follow-up (months)
1 MA F 79 Breast cancer Zoledronate (Zometa) 15 Extraction of # 43, 44 Mandible, Left anterior area ONJ 3 39 0.5 27, deceased
2 IG F 77 Osteoporosis Alendronate (Fosavance) 35 Extraction of # 46 Mandible, Posterior at # 46 ONJ 2/3 88 0 38
3 DF M 68 Multiple myeloma Zoledronate (Zometa) 38 Extraction of # 36,37, 46,47 Mandible, Bilat. posterior at # 36,37 & 46,47 ONJ 3 110 6 32
4 BA M 77 Prostate cancer Zoledronate (Zometa) 33 Traumatic ill-fitted prosthesis Mandible, Anterior at # 33,34 ONJ 2 90 3 26
5 SM F 81 Osteoporosis Alendronate (Fosavance) 32 Extraction of # 11,12 Maxilla, Anterior at # 11,12 ONJ 2 80 0 23
6 GP M 60 Multiple myelome Zoledronate (Zometa) 20 Extraction of # 16,17 Maxilla, Posterior at # 16,17 ONJ 3 53 1 15
7 NL F 69 Osteoporosis Alendronate (Alendros 70) 70 Extraction of # 47 Mandible, Posterior at # 47 ONJ 2 183 3 14
8 MS F 59 Multiple myelome Zoledronate (Zometa) 13 Extraction of # 43, 44 Mandible, Left anterior area ONJ 2 35 1 13

Back to Article